Hailey J. Wyatt

Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

MRI of combination immunotherapy in an epithelial ovarian cancer preclinical model.

MRI of combination immunotherapy in an epithelial ovarian cancer preclinical model.

Journal: Npj imaging

Published: September 25, 2025

Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche.

Hyperlipidemia-induced hematopoiesis is repressed by MLKL in endothelial cells of the splenic niche.

Journal: Nature cardiovascular research

Published: November 23, 2022

miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages.

miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages.

Journal: Circulation research

Published: May 25, 2022

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.

RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.

Journal: Circulation

Published: November 23, 2020

Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.

Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.

Journal: Nature metabolism

Published: October 09, 2020

Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis.

Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 28, 2020

RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.

RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.

Journal: Nature metabolism

Published: January 22, 2020

Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.

Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.

Journal: ACS nano

Published: May 25, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026